| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/17/2009 | US7504226 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |
| 03/17/2009 | US7504111 Protein from gonococcus (Neisseria gonorrhoeae), including a specific amino acid sequence; antigens for vaccines, immunogenic compositions, and/or diagnostics; useful for distinguishing between gonococcus and meningococcus |
| 03/17/2009 | US7504108 Polypeptides; immunogenic compositions; generating immune responses; kits |
| 03/17/2009 | US7504107 pretreatment step involving a highly specific and high affinity neutralizing antibody |
| 03/17/2009 | US7504106 Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis |
| 03/17/2009 | US7504105 Antibody for diagnosising immunology disorders |
| 03/17/2009 | US7504104 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens |
| 03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
| 03/17/2009 | US7504101 Methods for enhancing antigen-specific immune response using antibodies that bind OX-40 |
| 03/17/2009 | US7504092 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 03/17/2009 | US7504087 Receptor-avid exogenous optical contrast and therapeutic agents |
| 03/17/2009 | CA2493558C Methods for detecting or assaying virus |
| 03/17/2009 | CA2262546C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 03/17/2009 | CA2191895C Toxin assay |
| 03/12/2009 | WO2009145838A2 Cellular production of glucaric acid |
| 03/12/2009 | WO2009033095A2 Humanized pai-1 antibodies |
| 03/12/2009 | WO2009033094A2 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | WO2009033013A1 Antibodies against flagellin and uses thereof |
| 03/12/2009 | WO2009032782A2 Compositions that bind multiple epitopes of igf-1r |
| 03/12/2009 | WO2009032352A1 Macrocyclic compounds and methods of treatment |
| 03/12/2009 | WO2009032351A1 Natural product agents, derivatives, and methods of treatment |
| 03/12/2009 | WO2009032145A1 Anti-igf-1r antibodies and uses thereof |
| 03/12/2009 | WO2009032128A1 Compositions and methods comprising binding proteins for adalimumab |
| 03/12/2009 | WO2009031818A2 Biomarker for purification or identification of mesenchymal stem cells and methods of purification of mesenchymal stem cells by using it |
| 03/12/2009 | WO2009031351A1 Method of detecting viral antigen and kit for detecting viral antigen |
| 03/12/2009 | WO2009031230A1 Anti-cd20 monoclonal antibodies |
| 03/12/2009 | WO2009031228A1 Method of detecting viral antigen and kit for detecting viral antigen |
| 03/12/2009 | WO2009031151A2 Antibodies and methods for diagnosing and treating cancer |
| 03/12/2009 | WO2009031045A2 Anti-chikungunya monoclonal antibodies and uses thereof |
| 03/12/2009 | WO2009030978A2 Conformers of bacterial adhesins |
| 03/12/2009 | WO2009030936A1 Method for the treatment of glomerulonephritis |
| 03/12/2009 | WO2009030884A2 Mannosylated butyrophilin tumour markers |
| 03/12/2009 | WO2009030734A1 Intraoperative trifunctional antibody administration for prophylaxis of intraperitoneal tumor cell dissemination |
| 03/12/2009 | WO2009030500A1 Bone morphogenetic protein (bmp)-binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and use of same |
| 03/12/2009 | WO2009030368A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 03/12/2009 | WO2009030285A1 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 03/12/2009 | WO2009030239A1 Novel methods and antibodies for treating cancer |
| 03/12/2009 | WO2009030237A2 Methods for recombinant manufacturing of anti-rsv antibodies |
| 03/12/2009 | WO2009030094A1 Function and use of new lysosome-associated apoptosis-inducing protein containing ph and fyve domains (lapf) |
| 03/12/2009 | WO2008152422A3 Binding proteins specific for insulin-like growth factors and uses thereof-909 |
| 03/12/2009 | WO2008146133A3 Hematopoietic cells that express mosc-1 |
| 03/12/2009 | WO2008135446A3 Klebsiella antigens |
| 03/12/2009 | WO2008122441A4 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 03/12/2009 | WO2008115504A3 Nucleic acids encoding humanized immunoglobulin that binds a4b7 integrin |
| 03/12/2009 | WO2008079849A3 Antibodies to insulin-like growth factor receptor |
| 03/12/2009 | WO2008017963A4 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof |
| 03/12/2009 | WO2006137815A3 Method for purifying mixtures of immunoglobulin & albumin |
| 03/12/2009 | WO2006020266A3 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 03/12/2009 | WO2005069970A3 Antibody specificity transfer using minimal essential binding determinants |
| 03/12/2009 | US20090070901 Modified rubisco large subunit n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1, 5-bisphosphate |
| 03/12/2009 | US20090070890 Product |
| 03/12/2009 | US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/12/2009 | US20090069546 Pyrazole-based cyanine dye |
| 03/12/2009 | US20090069545 Insecticidal proteins; biological pest control; genetic molecules encoding plant floral defensin-like molecules and their use in generating transgenic plants having resistance or at least reduced sensitivity to plant pests |
| 03/12/2009 | US20090069544 Humanized antibodies that recognize beta amyloid peptide |
| 03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
| 03/12/2009 | US20090069500 Label target and labeling reagents comprising rigid group backbones |
| 03/12/2009 | US20090069274 Interferon-like protein zcyto21 |
| 03/12/2009 | US20090069258 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 03/12/2009 | US20090069243 Natriuretic activities |
| 03/12/2009 | US20090069229 Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences |
| 03/12/2009 | US20090068737 Methods of inhibiting interleukin-17 receptor |
| 03/12/2009 | US20090068732 Directed evolution methods for improving polypeptide folding and solubility and superfolder fluorescent proteins generated thereby |
| 03/12/2009 | US20090068719 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 03/12/2009 | US20090068692 Using preferential protein expression profile in cervicovaginal and/or vaginal fluids to identify pregnant humans suffering from prolonged rupture of membranes (PROM) |
| 03/12/2009 | US20090068684 Serine and threoninephosphorylation sites |
| 03/12/2009 | US20090068679 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof |
| 03/12/2009 | US20090068663 predicting in an individual the likelihood of developing cancer; genotyping; familial adenomatous polyposis (FAP), attenuated FAP (AFAP), or hereditary non-polyposis colorectal cancer (HNPCC) syndrome |
| 03/12/2009 | US20090068637 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and use thereof |
| 03/12/2009 | US20090068636 Viral protein |
| 03/12/2009 | US20090068218 Antigens for Vaccination Against and Detection of Mycoplasma Suis |
| 03/12/2009 | US20090068213 Immunogenic composition for early detection of dengue virus |
| 03/12/2009 | US20090068212 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans |
| 03/12/2009 | US20090068206 Delivery of pharmaceutical agents via the human insulin receptor |
| 03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 03/12/2009 | US20090068203 Methods for treating cardiovascular disease using a soluble CTLA4 Molecule |
| 03/12/2009 | US20090068202 Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 03/12/2009 | US20090068201 Methods of treatment using antibodies to neutrokine-alpha |
| 03/12/2009 | US20090068198 Antibody and Uses Thereof |
| 03/12/2009 | US20090068194 Antibodies and Their Use In The Treatment, Prevention and Diagnosis of a Disease Associated With SOD1 Abnormalities |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068192 The antibodies are immunomodulators of diseases such as cancer, autoimmune, inflammatory and infectious diseases |
| 03/12/2009 | US20090068191 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of the Pseudomonas Aeruginosa IATS 011 Serotype |
| 03/12/2009 | US20090068189 Monoclonal Antibody to Human TGF-Beta Induced Gene-H3 and Use Thereof |
| 03/12/2009 | US20090068188 C-C chemokine receptor 3 proteins |
| 03/12/2009 | US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor |
| 03/12/2009 | US20090068184 Major histocompatibility complex polypeptide hybrid for use in prevention and/or treatment of infection, inflammatory, autoimmune and/or malignancy |
| 03/12/2009 | US20090068183 Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 03/12/2009 | US20090068182 Cytotoxicity mediation of cells evidencing surface expression of CD9 |
| 03/12/2009 | US20090068181 Bispecific antibodies |
| 03/12/2009 | US20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin |
| 03/12/2009 | US20090068177 Optimized Fc variants and methods for their generation |
| 03/12/2009 | US20090068175 Optimized FC Variants and Methods for Their Generation |
| 03/12/2009 | US20090068172 Compositions and methods comprising binding proteins for adalimumab |
| 03/12/2009 | US20090068110 Antibodies to insulin-like growth factor receptor |
| 03/12/2009 | US20090068109 Anti-mcp-1 antibodies, compositions, methods and uses |
| 03/12/2009 | US20090068106 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 03/12/2009 | US20090068100 Cancerous disease modifying antibodies |
| 03/12/2009 | US20090068099 Cancerous disease modifying antibodies |
| 03/12/2009 | US20090068098 Antibodies and related molecules that bind to 58p1d12 proteins |